Onco-Innovations Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:ONNV.F Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
23 Apr 26	SellUS$20,173	Carnarvon Strategies - Health Industry Solutions Inc.	Company	20,000	US$1.02
22 Apr 26	SellUS$18,300	Richard Heinzl	Individual	20,000	US$0.92
16 Jan 26	SellUS$5,327	Richard Heinzl	Individual	5,700	US$0.93
13 Jan 26	SellUS$2,433	Richard Heinzl	Individual	2,600	US$0.94
05 Nov 25	SellUS$14,497	Richard Heinzl	Individual	11,700	US$1.24

Insider Trading Volume

Insider Buying: ONNV.F insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONNV.F?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	572,700	0.961%
Private Companies	692,300	1.16%
General Public	58,300,858	97.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 8 shareholders own 2.12% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
1.16%	Carnarvon Strategies - Health Industry Solutions Inc.	692,300	US$412.0k	-2.81%	no data
0.33%	Richard Heinzl	197,500	US$117.5k	-5.95%	no data
0.3%	Islam Mohamed	177,500	US$105.6k	0%	no data
0.13%	Thomas O’Shaughnessy	75,200	US$44.8k	99.5%	no data
0.11%	Nico Mah	65,000	US$38.7k	30%	no data
0.034%	Christopher Gulka	20,000	US$11.9k	100%	no data
0.034%	Jared Rushton	20,000	US$11.9k	0%	no data
0.029%	Maximilian Justus	17,500	US$10.4k	133%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/09 09:27
End of Day Share Price	2026/06/09 00:00
Earnings	2026/01/31
Annual Earnings	2025/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Onco-Innovations Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.